المؤلفون: Hiroaki Akamatsu, MD, PhD, Shunsuke Teraoka, MD, Hidetoshi Hayashi, MD, PhD, Daichi Fujimoto, MD, Atsushi Hayata, MD, PhD, Koji Haratani, MD, PhD, Yuichi Ozawa, MD, PhD, Takeshi Yoshida, MD, PhD, Tsutomu Iwasa, MD, PhD, Toshio Shimokawa, MD, Keisuke Tomii, MD, PhD, Kazuhiko Nakagawa, MD, PhD, Nobuyuki Yamamoto, MD, PhD

المصدر: JTO Clinical and Research Reports, Vol 2, Iss 7, Pp 100184- (2021)

مصطلحات موضوعية: Small cell lung cancer, Pembrolizumab, Amrubicin, Refractory, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2666364321000436; https://doaj.org/toc/2666-3643

URL الوصول: https://doaj.org/article/772e441e14ed494d9dc68a90b6f84b8f